363 results on '"Buglioni, Simonetta"'
Search Results
2. Monitoring changing patterns in HER2 addiction by liquid biopsy in advanced breast cancer patients
3. Kirsten Rat Sarcoma Virus Mutations Effect On Tumor Doubling Time And Prognosis Of Solid Dominant Stage I Lung Adenocarcinoma
4. Identification of a set of genes potentially responsible for resistance to ferroptosis in lung adenocarcinoma cancer stem cells
5. The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world
6. Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment
7. Multicenter Evaluation of the Idylla GeneFusion in Non–Small-Cell Lung Cancer
8. KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to Immunotherapy
9. FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma
10. p53 and BLC2 Immunohistochemical Expression Across Molecular Subtypes in 1099 Early Breast Cancer Patients With Long-Term Follow-up: An Observational Study
11. Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma
12. Identification of a set of genes potentially responsible for resistance to ferroptosis in lung adenocarcinoma cancer stem cells
13. Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer
14. USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer
15. Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC
16. European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors
17. BRAF status modulates Interelukin-8 expression through a CHOP-dependent mechanism in colorectal cancer
18. TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients
19. Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells
20. Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
21. Pretreated EGFR/BRAF Lung Adenocarcinoma With Leptomeningeal Disease Achieving Long-Lasting Disease Control on Osimertinib, Dabrafenib, and Trametinib: A Case Report
22. microRNA-378a-5p iS a novel positive regulator of melanoma progression
23. PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes
24. An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples
25. Development of a Somatic Variant Registry in a National Cancer Center: towards Molecular Real World Data preparedness
26. ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinoma
27. Supplementary Figures and Table with legends from Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS–Dependent Pancreatic Ductal Adenocarcinoma
28. Supplementary Materials and Methods from Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS–Dependent Pancreatic Ductal Adenocarcinoma
29. Supplementary Materials and Methods from Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem–Like Cells and Reduces Metastases through Effects on Lipid Anabolism
30. Supplementary Figure S1 from HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care
31. Data from Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS–Dependent Pancreatic Ductal Adenocarcinoma
32. Supplementary Data from Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem–Like Cells and Reduces Metastases through Effects on Lipid Anabolism
33. Data from Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem–Like Cells and Reduces Metastases through Effects on Lipid Anabolism
34. Supplementary Tables and Figures from Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem–Like Cells and Reduces Metastases through Effects on Lipid Anabolism
35. Supplementary Table S1 from HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care
36. ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinoma
37. An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples
38. Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb
39. Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer
40. Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer
41. Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations
42. Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic Biomarker
43. A Real-World Systematic Analysis of Driver Mutations’ Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting
44. Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma
45. BCL-XL overexpression promotes tumor progression-associated properties
46. Analysis of Molecular Biomarkers in Resected Early-Stage Non-Small Cells Lung Cancer: A Narrative Review
47. HIPK2 Cooperates with KRAS Signaling and Associates with Colorectal Cancer Progression
48. Pitfalls in Molecular Testing and the Added Value of the Cancer Research Biomedical Community
49. Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non–Small-Cell Lung Cancer
50. [Mutational oncology of lung cancer: molecular markers, drugs, negotiation conditions and experiences in national reference centers.]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.